Direct evidence in men for a role of endogenous oestrogens on gonadotrophin release
- 1 June 1981
- journal article
- research article
- Published by Oxford University Press (OUP) in Acta Endocrinologica
- Vol. 97 (2) , 145-149
- https://doi.org/10.1530/acta.0.0970145
Abstract
In 6 healthy subjects serum estradiol was selectively decreased by administering an aromatase activity inhibitor, hydrotestolactone (HT). After HT administration serum estradiol (E2) decreased from 18.7 .+-. 2.3 (SEM [standard error of the mean]) to 6.7 .+-. 0.6 pg/ml, whereas testosterone (T) and dihydrotestosterone blood levels were not modified. These E2 changes were associated with a singificant increase in serum LH [luteinizing hormone] and FSH [follicle stimulating hormone] concentrations (P < 0.001). Tamoxifen administration an estrogen antagonist, to 5 subjects caused a sharp increase in LH and FSH levels (P < 0.001). E2 was unchanged after the treatment with tamoxifen, whereas T levels were significantly higher. Apparently estradiol under physiological conditions plays a specific role in the feedback mechanism of gonadotropin release.This publication has 8 references indexed in Scilit:
- Evidence That Testosterone Can Suppress Pituitary Gonadotropin Secretion Independently of Peripheral Aromatization*Journal of Clinical Endocrinology & Metabolism, 1979
- Estradiol Formation from Testosterone by Continuously Cultured Human Breast Cancer Cells*Journal of Clinical Endocrinology & Metabolism, 1979
- Studies on the Role of Sex Steroids in the Feedback Control of Gonadotropin Concentrations in Men. II. Use of the Estrogen Antagonist, Clomiphene Citrate*Journal of Clinical Endocrinology & Metabolism, 1979
- Hormonal Effects of an Antiestrogen, Tamoxifen, in Normal and Oligospermic MenFertility and Sterility, 1978
- Assessments of the Functional Capacity of the Gonadotrophs in Men: Effects of Estrogen and ClomipheneJournal of Clinical Endocrinology & Metabolism, 1976
- EFFECT OF OESTRADIOL ON GONADOTROPHIN RELEASE INDUCED BY LHRH IN MENClinical Endocrinology, 1976
- Metabolic clearance rates and interconversions of estrone and 17β-estradiol in normal males and femalesJournal of Clinical Investigation, 1968
- Δ1-testololactone, a nonandrogenic augmentor and inhibitor of androgensCancer, 1960